Papers

4

Total Citations

104

H-Index

4

About

Ralf-Thorsten Hoffmann is a clinician-researcher whose work sits at the intersection of interventional radiology, radiation oncology, and minimally invasive surgery, with a particular focus on advancing local treatment strategies for oncological disease. His most influential contributions center on the comparative evaluation of percutaneous radiofrequency ablation (RFA) and robotic radiosurgery (RRS) for salvage treatment of colorectal liver metastases, a landmark 2013 study that has garnered 56 citations and helped clarify the respective roles of these modalities in heavily pretreated patient populations. Hoffmann has been a consistent advocate for robotic radiosurgical platforms, authoring foundational clinical work on CyberKnife®-based treatment of both liver and lung tumors, including early feasibility data on single-session lung radiosurgery with real-time respiratory tracking. More recently, his research has expanded into robotic surgical oncology, with a 2022 propensity score-matched analysis demonstrating that robotic esophagectomy reduces postoperative sarcopenia compared to open approaches — an emerging and clinically meaningful outcome measure. Across his career, Hoffmann's scholarship reflects a sustained commitment to refining minimally invasive and image-guided techniques to improve oncological outcomes and patient recovery.

Research Focus

Key Achievements

4
H-Index
4
Papers
104
Total Citations
26
Avg Citations/Paper
🏆 Most Cited Paper
Percutaneous radiofrequency ablation (RFA) or robotic radiosurgery (RRS) for salvage treatment of colorectal liver metastases
56 citations · 2013
📈 Most Prolific Year: 2013 (1 Papers)
🤝 Key Collaborators: 26
🏛 Institutions: University Hospital Carl Gustav Carus, Ludwig-Maximilians-Universität München, German Cancer Research Center

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago